nach oben

Erschienen in:

16.10.2017 | Original Article

The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society

verfasst von: Lori Kennedy Madden, Michelle Hill, Teresa L. May, Theresa Human, Mary McKenna Guanci, Judith Jacobi, Melissa V. Moreda, Neeraj Badjatia

Erschienen in: Neurocritical Care | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Targeted temperature management (TTM) is often used in neurocritical care to minimize secondary neurologic injury and improve outcomes. TTM encompasses therapeutic hypothermia, controlled normothermia, and treatment of fever. TTM is best supported by evidence from neonatal hypoxic-ischemic encephalopathy and out-of-hospital cardiac arrest, although it has also been explored in ischemic stroke, traumatic brain injury, and intracranial hemorrhage patients. Critical care clinicians using TTM must select appropriate cooling techniques, provide a reasonable rate of cooling, manage shivering, and ensure adequate patient monitoring among other challenges.

Methods

The Neurocritical Care Society recruited experts in neurocritical care, nursing, and pharmacotherapy to form a writing Committee in 2015. The group generated a set of 16 clinical questions relevant to TTM using the PICO format. With the assistance of a research librarian, the Committee undertook a comprehensive literature search with no back date through November 2016 with additional references up to March 2017.

Results

The Committee utilized GRADE methodology to adjudicate the quality of evidence as high, moderate, low, or very low based on their confidence that the estimate of effect approximated the true effect. They generated recommendations regarding the implementation of TTM based on this systematic review only after considering the quality of evidence, relative risks and benefits, patient values and preferences, and resource allocation.

Conclusion

This guideline is intended for neurocritical care clinicians who have chosen to use TTM in patient care; it is not meant to provide guidance regarding the clinical indications for TTM itself. While there are areas of TTM practice where clear evidence guides strong recommendations, many of the recommendations are conditional, and must be contextualized to individual patient and system needs.

Nur mit Berechtigung zugänglich

Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557–63.PubMedCrossRef

Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353(15):1574–84.PubMedCrossRef

Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, Fung GL, Goldstein JN, Macdonald RL, Mitchell PH, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.PubMedCrossRef

Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.PubMedCrossRef

Diringer MN, Bleck TP, Claude Hemphill J III, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.PubMedCrossRef

Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.PubMedCrossRef

Geocadin RG, Wijdicks E, Armstrong MJ, Damian M, Mayer SA, Ornato JP, Rabinstein A, Suarez JI, Torbey MT, Dubinsky RM, et al. Practice guideline summary: reducing brain injury following cardiopulmonary resuscitation: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017;88(22):2141–9.PubMedCrossRef

Callaway CW, Donnino MW, Fink EL, Geocadin RG, Golan E, Kern KB, Leary M, Meurer WJ, Peberdy MA, Thompson TM, et al. Part 8: post-cardiac arrest care: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S465–82.PubMedPubMedCentralCrossRef

Committee on F, Newborn, Papile LA, Baley JE, Benitz W, Cummings J, Carlo WA, Eichenwald E, Kumar P, Polin RA et al: Hypothermia and neonatal encephalopathy. Pediatrics 2014, 133(6):1146–1150.CrossRef

10.

Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6–15.PubMed

11.

Trauma Quality Improvement Program (TQIP). Best Practices in the Management of Traumatic Brain Injury. In: American College of Surgeons Committee on Trauma. 2015. https://www.facs.org/~/media/files/quality%20programs/trauma/tqip/traumatic%20brain%20injury%20guidelines.ashx. Accessed Jan 2017.

12.

Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, Rind D, Montori VM, Brito JP, Norris S, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726–35.PubMedCrossRef

13.

Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schunemann HJ, Group GW: Going from evidence to recommendations. BMJ 2008, 336(7652):1049–1051,.

14.

Donnino MW, Andersen LW, Berg KM, Reynolds JC, Nolan JP, Morley PT, Lang E, Cocchi MN, Xanthos T, Callaway CW, et al. Temperature management after cardiac arrest: an advisory statement by the advanced life support task force of the international liaison committee on resuscitation and the American Heart Association emergency cardiovascular care committee and the council on cardiopulmonary, critical care, perioperative and resuscitation. Circulation. 2015;132(25):2448–56.PubMedCrossRef

15.

Kochanek PM, Carney N, Adelson PD, Ashwal S, Bell MJ, Bratton S, Carson S, Chesnut RM, Ghajar J, Goldstein B, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents–second edition. Pediatr Crit Care Med. 2012;13(Suppl 1):S1–82.PubMed

16.

Jiang JY, Xu W, Li WP, Gao GY, Bao YH, Liang YM, Luo QZ. Effect of long-term mild hypothermia or short-term mild hypothermia on outcome of patients with severe traumatic brain injury. J Cereb Blood Flow Metab. 2006;26(6):771–6.PubMedCrossRef

17.

Laish-Farkash A, Matetzky S, Kassem S, Haj-Iahia H, Hod H. Therapeutic hypothermia for comatose survivors after cardiac arrest. IMAJ. 2007;9(4):252–6.PubMed

18.

Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Tateishi Y, Nakanishi K, Kitamura N, Hirasawa H. Duration of well-controlled core temperature correlates with neurological outcome in patients with post-cardiac arrest syndrome. Am J Emerg Med. 2012;30(9):1838–44.PubMedCrossRef

19.

Shankaran S, Laptook AR, Pappas A, McDonald SA, Das A, Tyson JE, Poindexter BB, Schibler K, Bell EF, Heyne RJ, et al. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA. 2014;312(24):2629–39.PubMedPubMedCentralCrossRef

20.

The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–56.CrossRef

21.

Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, Muizelaar JP, Wagner FC Jr, Marion DW, Luerssen TG, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001;344(8):556–63.PubMedCrossRef

22.

Aibiki M, Maekawa S, Yokono S. Moderate hypothermia improves imbalances of thromboxane A2 and prostaglandin I2 production after traumatic brain injury in humans. Crit Care Med. 2000;28(12):3902–6.PubMedCrossRef

23.

Clifton GL, Allen S, Barrodale P, Plenger P, Berry J, Koch S, Fletcher J, Hayes RL, Choi SC: A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993, 10(3):263-271; discussion 273.

24.

Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, Janis LS, Wilde E, Taylor P, Harshman K, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: hypothermia II): a randomised trial. Lancet Neurol. 2011;10(2):131–9.PubMedCrossRef

25.

Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek PM, Palmer AM, Wisniewski SR, DeKosky ST. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med. 1997;336(8):540–6.PubMedCrossRef

26.

Qiu WS, Liu WG, Shen H, Wang WM, Hang ZL, Zhang Y, Jiang SJ, Yang XF. Therapeutic effect of mild hypothermia on severe traumatic head injury. Chin J Traumatol. 2005;8(1):27–32.PubMed

27.

Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L). Stroke. 2010;41(10):2265–70.PubMedPubMedCentralCrossRef

28.

Lyden P, Hemmen T, Grotta J, Rapp K, Ernstrom K, Rzesiewicz T, Parker S, Concha M, Hussain S, Agarwal S, et al. Results of the ICTuS 2 trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke. 2016;47(12):2888–95.PubMedCrossRef

29.

Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, Murray GD, Eurotherm Trial C. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373(25):2403–12.PubMedCrossRef

30.

Badjatia N, Fernandez L, Schmidt JM, Lee K, Claassen J, Connolly ES, Mayer SA. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neurosurgery. 2010;66(4):696–700.PubMedCrossRef

31.

Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, Kuppers-Tiedt L, Schneider D, Schmutzhard E. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009;40(12):e657–65.PubMedCrossRef

32.

Diringer MN. Neurocritical care fever reduction trial G: treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 2004;32(2):559–64.PubMedCrossRef

33.

Puccio AM, Fischer MR, Jankowitz BT, Yonas H, Darby JM, Okonkwo DO. Induced normothermia attenuates intracranial hypertension and reduces fever burden after severe traumatic brain injury. Neurocrit Care. 2009;11(1):82–7.PubMedPubMedCentralCrossRef

34.

Lord AS, Karinja S, Lantigua H, Carpenter A, Schmidt JM, Claassen J, Agarwal S, Connolly ES, Mayer SA, Badjatia N. Therapeutic temperature modulation for fever after intracerebral hemorrhage. Neurocrit Care. 2014;21(2):200–6.PubMedCrossRef

35.

MacLellan CL, Clark DL, Silasi G, Colbourne F. Use of prolonged hypothermia to treat ischemic and hemorrhagic stroke. J Neurotrauma. 2009;26(3):313–23.PubMedCrossRef

36.

Hoedemaekers CW, Ezzahti M, Gerritsen A, van der Hoeven JG. Comparison of cooling methods to induce and maintain normo- and hypothermia in intensive care unit patients: a prospective intervention study. Crit Care. 2007;11(4):R91.PubMedPubMedCentralCrossRef

37.

Akula VP, Joe P, Thusu K, Davis AS, Tamaresis JS, Kim S, Shimotake TK, Butler S, Honold J, Kuzniewicz M et al: A randomized clinical trial of therapeutic hypothermia mode during transport for neonatal encephalopathy. J Pediatr 2015, 166(4):856–861 e851–852.

38.

Poli S, Purrucker J, Priglinger M, Ebner M, Sykora M, Diedler J, Bulut C, Popp E, Rupp A, Hametner C. Rapid Induction of COOLing in Stroke Patients (iCOOL1): a randomised pilot study comparing cold infusions with nasopharyngeal cooling. Crit Care. 2014;18(5):582.PubMedPubMedCentralCrossRef

39.

Deye N, Cariou A, Girardie P, Pichon N, Megarbane B, Midez P, Tonnelier JM, Boulain T, Outin H, Delahaye A, et al. Endovascular versus external targeted temperature management for patients with out-of-hospital cardiac arrest: a randomized. Controlled Study. Circulation. 2015;132(3):182–93.PubMedCrossRef

40.

Pittl U, Schratter A, Desch S, Diosteanu R, Lehmann D, Demmin K, Horig J, Schuler G, Klemm T, Mende M, et al. Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial. Clin Res Cardiol. 2013;102(8):607–14.PubMedCrossRef

41.

Heard KJ, Peberdy MA, Sayre MR, Sanders A, Geocadin RG, Dixon SR, Larabee TM, Hiller K, Fiorello A, Paradis NA, et al. A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest. Resuscitation. 2010;81(1):9–14.PubMedCrossRef

42.

Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, Eichwede F, Mols P, Schwab T, Vergnion M, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010;122(7):729–36.PubMedCrossRef

43.

Bernard SA, Smith K, Finn J, Hein C, Grantham H, Bray JE, Deasy C, Stephenson M, Williams TA, Straney LD, et al. Induction of therapeutic hypothermia during out-of-hospital cardiac arrest using a rapid infusion of cold saline: the rinse trial (rapid infusion of cold normal saline). Circulation. 2016;134(11):797–805.PubMedCrossRef

44.

de Waard MC, Banwarie RP, Jewbali LS, Struijs A, Girbes AR, Groeneveld AB. Intravascular versus surface cooling speed and stability after cardiopulmonary resuscitation. Emerg Med J. 2015;32(10):775–80.PubMedCrossRef

45.

Arulkumaran N, Suleman R, Ball J. Use of ice-cold crystalloid for inducing mild therapeutic hypothermia following out-of-hospital cardiac arrest. Resuscitation. 2012;83(2):151–8.PubMedCrossRef

46.

Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: a preliminary report. Resuscitation. 2003;56(1):9–13.PubMedCrossRef

47.

Jacobshagen C, Pax A, Unsold BW, Seidler T, Schmidt-Schweda S, Hasenfuss G, Maier LS. Effects of large volume, ice-cold intravenous fluid infusion on respiratory function in cardiac arrest survivors. Resuscitation. 2009;80(11):1223–8.PubMedCrossRef

48.

Polderman KH, Rijnsburger ER, Peerdeman SM, Girbes AR. Induction of hypothermia in patients with various types of neurologic injury with use of large volumes of ice-cold intravenous fluid. Crit Care Med. 2005;33(12):2744–51.PubMedCrossRef

49.

Hammer L, Vitrat F, Savary D, Debaty G, Santre C, Durand M, Dessertaine G, Timsit JF. Immediate prehospital hypothermia protocol in comatose survivors of out-of-hospital cardiac arrest. Am J Emerg Med. 2009;27(5):570–3.PubMedCrossRef

50.

Badjatia N, Bodock M, Guanci M, Rordorf GA. Rapid infusion of cold saline (4 degrees C) as adjunctive treatment of fever in patients with brain injury. Neurology. 2006;66(11):1739–41.PubMedCrossRef

51.

Fink EL, Kochanek PM, Clark RS, Bell MJ. Fever control and application of hypothermia using intravenous cold saline. Pediatr Crit Care Med. 2012;13(1):80–4.PubMedPubMedCentralCrossRef

52.

Rana M, J WS, Saygili E, Hameed U, Benke D, Hoffmann R, Schauerte P, Marx N, Rana OR: Comparative evaluation of the usability of 2 different methods to perform mild hypothermia in patients with out-of-hospital cardiac arrest. Int J Cardiol 2011, 152(3):321–326.

53.

Hoque N, Chakkarapani E, Liu X, Thoresen M. A comparison of cooling methods used in therapeutic hypothermia for perinatal asphyxia. Pediatrics. 2010;126(1):e124–30.PubMedCrossRef

54.

Flint AC, Hemphill JC, Bonovich DC. Therapeutic hypothermia after cardiac arrest: performance characteristics and safety of surface cooling with or without endovascular cooling. Neurocrit Care. 2007;7(2):109–18.PubMedCrossRef

55.

Knapik P, Rychlik W, Duda D, Golyszny R, Borowik D, Ciesla D. Relationship between blood, nasopharyngeal and urinary bladder temperature during intravascular cooling for therapeutic hypothermia after cardiac arrest. Resuscitation. 2012;83(2):208–12.PubMedCrossRef

56.

Laptook AR, Kilbride H, Shepherd E, McDonald SA, Shankaran S, Truog W, Das A, Higgins RD, Optimizing Cooling S-C. Temperature control during therapeutic hypothermia for newborn encephalopathy using different Blanketrol devices. Ther Hypothermia Temp Manag. 2014;4(4):193–200.PubMedPubMedCentralCrossRef

57.

Haugk M, Stratil P, Sterz F, Krizanac D, Testori C, Uray T, Koller J, Behringer W, Holzer M, Herkner H. Temperature monitored on the cuff surface of an endotracheal tube reflects body temperature. Crit Care Med. 2010;38(7):1569–73.PubMedCrossRef

58.

Krizanac D, Stratil P, Hoerburger D, Testori C, Wallmueller C, Schober A, Haugk M, Haller M, Behringer W, Herkner H, et al. Femoro-iliacal artery versus pulmonary artery core temperature measurement during therapeutic hypothermia: an observational study. Resuscitation. 2013;84(6):805–9.PubMedCrossRef

59.

Markota A, Palfy M, Stozer A, Sinkovic A. Difference Between Bladder and Esophageal Temperatures in Mild Induced Hypothermia. J Emerg Med. 2015;49(1):98–103.PubMedCrossRef

60.

Hasper D, Nee J, Schefold JC, Krueger A, Storm C. Tympanic temperature during therapeutic hypothermia. Emerg Med J. 2011;28(6):483–5.PubMedCrossRef

61.

Stelfox HT, Straus SE, Ghali WA, Conly J, Laupland K, Lewin A. Temporal artery versus bladder thermometry during adult medical-surgical intensive care monitoring: an observational study. BMC Anesthesiol. 2010;10(13):13.PubMedPubMedCentralCrossRef

62.

Zeiner A, Klewer J, Sterz F, Haugk M, Krizanac D, Testori C, Losert H, Ayati S, Holzer M. Non-invasive continuous cerebral temperature monitoring in patients treated with mild therapeutic hypothermia: an observational pilot study. Resuscitation. 2010;81(7):861–6.PubMedCrossRef

63.

Badjatia N, Strongilis E, Gordon E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Ostapkovich ND, Mayer SA. Metabolic impact of shivering during therapeutic temperature modulation: the bedside shivering assessment scale. Stroke. 2008;39(12):3242–7.PubMedCrossRef

64.

Oddo M, Frangos S, Maloney-Wilensky E, Andrew Kofke W, Le Roux PD, Levine JM. Effect of shivering on brain tissue oxygenation during induced normothermia in patients with severe brain injury. Neurocrit Care. 2010;12(1):10–6.PubMedCrossRef

65.

Frank SM, Higgins MS, Fleisher LA, Sitzmann JV, Raff H, Breslow MJ. Adrenergic, respiratory, and cardiovascular effects of core cooling in humans. Am J Physiol. 1997;272(2 Pt 2):R557–62.PubMed

66.

Olson DM, Grissom JL, Williamson RA, Bennett SN, Bellows ST, James ML. Interrater reliability of the bedside shivering assessment scale. Am J Crit care. 2013;22(1):70–4.PubMedCrossRef

67.

May T, Seder DB, Fraser GL, Tu C, McCrum B, Lucas L, Riker RR. Association of the Bedside Shivering Assessment Scale and derived EMG power during therapeutic hypothermia in survivors of cardiac arrest. Resuscitation. 2011;82(8):1100–3.PubMedCrossRef

68.

Sund-Levander M, Wahren LK. Assessment and prevention of shivering in patients with severe cerebral injury. A pilot study. J Clin Nurs. 2000;9(1):55–61.PubMedCrossRef

69.

Earp JK, Finlayson DC. Urinary bladder/pulmonary artery temperature ratio of less than 1 and shivering in cardiac surgical patients. Am J Crit Care. 1992;1(2):43–52.PubMed

70.

Choi HA, Ko SB, Presciutti M, Fernandez L, Carpenter AM, Lesch C, Gilmore E, Malhotra R, Mayer SA, Lee K, et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care. 2011;14(3):389–94.PubMedCrossRef

71.

Logan A, Sangkachand P, Funk M. Optimal management of shivering during therapeutic hypothermia after cardiac arrest. Crit Care Nurse. 2011;31(6):e18–30.PubMedCrossRef

72.

Avery KR, O’Brien M, Pierce CD, Gazarian PK. Use of a nursing checklist to facilitate implementation of therapeutic hypothermia after cardiac arrest. Crit care nurse. 2015;35(1):29–37.PubMedCrossRef

73.

Presciutti M, Bader MK, Hepburn M. Shivering management during therapeutic temperature modulation: nurses’ perspective. Crit Care Nurse. 2012;32(1):33–42.PubMedCrossRef

74.

Park B, Lee T, Berger K, Park SM, Choi KE, Goodsell TM, Rosengart A. Efficacy of nonpharmacological antishivering interventions: a systematic analysis. Crit Care Med. 2015;43(8):1757–66.PubMedCrossRef

75.

Seder DB, Van der Kloot TE. Methods of cooling: practical aspects of therapeutic temperature management. Crit Care Med. 2009;37(7):S211–22.PubMedCrossRef

76.

Sessler DI. Thermoregulatory defense mechanisms. Crit Care Med. 2009;37(7):S203–10.PubMedCrossRef

77.

Mahmood MA, Zweifler RM. Progress in shivering control. J Neurol Sci. 2007;261(1–2):47–54.PubMedCrossRef

78.

Boulant JA. Neuronal basis of Hammel’s model for set-point thermoregulation. J Appl Physiol. 2006;100(4):1347–54.PubMedCrossRef

79.

Badjatia N, Kowalski RG, Schmidt JM, Voorhees ME, Claassen J, Ostapkovich ND, Presciutti M, Connolly ES, Palestrant D, Parra A, et al. Predictors and clinical implications of shivering during therapeutic normothermia. Neurocrit Care. 2007;6(3):186–91.PubMedCrossRef

80.

De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology. 2002;96(2):467–84.PubMedCrossRef

81.

Park SM, Mangat HS, Berger K, Rosengart AJ. Efficacy spectrum of antishivering medications: meta-analysis of randomized controlled trials. Crit Care Med. 2012;40(11):3070–82.PubMedCrossRef

82.

Callaway CW, Elmer J, Guyette FX, Molyneaux BJ, Anderson KB, Empey PE, Gerstel SJ, Holquist K, Repine MJ, Rittenberger JC. Dexmedetomidine reduces shivering during mild hypothermia in waking subjects. PLoS ONE. 2015;10(8):e0129709.PubMedPubMedCentralCrossRef

83.

Hostler D, Northington WE, Callaway CW. High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers. Appl Phys Nutr Metab. 2009;34(4):582–6.CrossRef

84.

Mokhtarani M, Mahgoub AN, Morioka N, Doufas AG, Dae M, Shaughnessy TE, Bjorksten AR, Sessler DI. Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg. 2001;93(5):1233–9.PubMedCrossRef

85.

Nihara Y, Kikuchi T, Sonoda Y, Nakamura K, Yamaguchi K, Kakihana Y. Efficacy of dexmedetomidine and propofol on shivering during mild hypothermia after cardiovascular surgery. Eur J Anesth S. 2013;30:189–90.

86.

Milne SE, James KS, Nimmo S, Hickey S. Oxygen consumption after hypothermic cardiopulmonary bypass: the effect of continuing a propofol infusion postoperatively. J Cardiothorac Vasc Anesth. 2002;16(1):32–6.PubMedCrossRef

87.

Lenhardt R, Orhan-Sungur M, Komatsu R, Govinda R, Kasuya Y, Sessler DI, Wadhwa A. Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers. Anesthesiology. 2009;111(1):110–5.PubMedCrossRef

88.

Zweifler RM, Voorhees ME, Mahmood MA, Parnell M. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke. 2004;35(10):2331–4.PubMedCrossRef

89.

Doufas AG, Lin CM, Suleman MI, Liem EB, Lenhardt R, Morioka N, Akca O, Shah YM, Bjorksten AR, Sessler DI. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke. 2003;34(5):1218–23.PubMedCrossRef

90.

Talke P, Tayefeh F, Sessler DI, Jeffrey R, Noursalehi M, Richardson C. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997;87(4):835–41.PubMedCrossRef

91.

Matsukawa T, Kurz A, Sessler DI, Bjorksten AR, Merrifield B, Cheng C. Propofol linearly reduces the vasoconstriction and shivering thresholds. Anesthesiology. 1995;82(5):1169–80.PubMedCrossRef

92.

Keegan SP, Hart KW, Adeoye OM, Bonomo JB, Lindsell CJ, Shutter L, Knight WA: Sedation and paralytic use during hypothermia after cardiac arrest. In: Neurocritical care. vol. 15; 2011: S219.

93.

Alfonsi P, Passard A, Gaude-joindreau V, Guignard B, Sessler DI, Chauvin M. Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not. Anesthesiology. 2009;111(1):102–9.PubMedCrossRef

94.

May T, Riker RR, Fraser GL, McCrum B, Gerst P, Stone P, Seder DB. Low-dose analgosedation during therapeutic hypothermia after cardiac arrest. Neurocrit Care. 2011;15(1):S212.

95.

Alfonsi P, Passard A, Guignard B, Chauvin M, Sessler DI. Nefopam and meperidine are infra-additive on the shivering threshold in humans. Anesth Analg. 2014;119(1):58–63.PubMedCrossRef

96.

Taniguchi Y, Ali SZ, Kimberger O, Zmoos S, Lauber R, Markstaller M, Kurz A. The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers. Anesth Analg. 2010;111(2):409–14.PubMedCrossRef

97.

Riker RR, Gagnon DJ, May T, Seder DB, Fraser GL. Analgesia, sedation, and neuromuscular blockade during targeted temperature management after cardiac arrest. Best Pract Res Clin Anaesthesiol. 2015;29(4):435–50.PubMedCrossRef

98.

Kimberger O, Ali SZ, Markstaller M, Zmoos S, Lauber R, Hunkeler C, Kurz A. Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study. Crit Care. 2007;11(1):R29.PubMedPubMedCentralCrossRef

99.

Kurz A, Ikeda T, Sessler DI, Larson MD, Bjorksten AR, Dechert M, Christensen R. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. Anesthesiology. 1997;86(5):1046–54.PubMedCrossRef

100.

Wadhwa A, Sengupta P, Durrani J, Akca O, Lenhardt R, Sessler DI, Doufas AG. Magnesium sulphate only slightly reduces the shivering threshold in humans. Br J Anaesth. 2005;94(6):756–62.PubMedPubMedCentralCrossRef

101.

Nicolaou G, Chen AA, Johnston CE, Kenny GP, Bristow GK, Giesbrecht GG. Clonidine decreases vasoconstriction and shivering thresholds, without affecting the sweating threshold. Can J Anaesth. 1997;44(6):636–42.PubMedCrossRef

102.

Delaunay L, Bonnet F, Liu N, Beydon L, Catoire P, Sessler DI. Clonidine comparably decreases the thermoregulatory thresholds for vasoconstriction and shivering in humans. Anesthesiology. 1993;79(3):470–4.PubMedCrossRef

103.

Jurado LV, Gulbis BE. Continuous infusion versus intermittent bolus dosing of vecuronium in patients receiving therapeutic hypothermia after sudden cardiac arrest. Pharmacotherapy. 2011;31(12):1250–6.PubMedCrossRef

104.

Salciccioli JD, Cocchi MN, Rittenberger JC, Peberdy MA, Ornato JP, Abella BS, Gaieski DF, Clore J, Gautam S, Giberson T, et al. Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. Resuscitation. 2013;84(12):1728–33.PubMedCrossRef

105.

Sladen RN, Berend JZ, Fassero JS, Zehnder EB. Comparison of vecuronium and meperidine on the clinical and metabolic effects of shivering after hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1995;9(2):147–53.PubMedCrossRef

106.

Lascarrou JB, Le Gouge A, Dimet J, Lacherade JC, Martin-Lefevre L, Fiancette M, Vinatier I, Lebert C, Bachoumas K, Yehia A, et al. Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: observational study of neurological and infectious outcomes. Resuscitation. 2014;85(9):1257–62.PubMedCrossRef

107.

Curtis J, Zettlemoyer G, Butler I. Neuromuscular blocking agents do not impact time to target temperature with therapeutic hypothermia. Crit Care Med. 2014;42(12):A1421.CrossRef

108.

Snider J, Vandenberg M, Thomas W, Bockheim H. Post cardiac arrest therapeutic hypothermia without neuromuscular blockade vs. Continuous or intermittent neuromuscular blockade. Crit Care Med. 2012;40(12):142.

109.

Fox M, Miller S, Danesh V, Health O, Liu-DeRyke X. Management of shivering with neuromuscular blocking agents during therapeutic hypothermia. Crit Care Med. 2012;40(12):235.

110.

Mayer KA, Pearson DA, Heffner A, Studnek J, Wares C, Ward SL, Kraft K, Runyon M. Timing of paralytics affects “door-to-cool” time in post-cardiac arrest patients. Acad Emerg Med. 2014;21(5):S98–9.

111.

Tanaka H, Mochizuki T, Ode S, Ishimatsu S. Factors involved in prolonged effect of neuromuscular blockade in therapeutic hypothermia. Crit Care. 2014;18:S181.CrossRef

112.

Sanuth B, Wang K. Neuromuscular blockers for shivering prevention during therapeutic hypothermia post cardiac arrest. Crit Care Med. 2015;43(12):54.CrossRef

113.

Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.PubMedCrossRef

114.

Komatsu R, Orhan-Sungur M, In J, Podranski T, Bouillon T, Lauber R, Rohrbach S, Sessler D. Ondansetron does not reduce the shivering threshold in healthy volunteers. Br J Anesth. 2006;96(6):732–7.CrossRef

115.

de Witte J, Deloof T, de Veylder J, Housmans PR. Tramadol in the treatment of postanesthetic shivering. Acta Anaesthesiol Scand. 1997;41(4):506–10.PubMedCrossRef

116.

Greif R, Laciny S, Rajek AM, Larson MD, Bjorksten AR, Doufas AG, Bakhshandeh M, Mokhtarani M, Sessler DI. Neither nalbuphine nor atropine possess special antishivering activity. Anesth Analg. 2001;93(3):620–7.PubMedCrossRef

117.

Nakajima Y, Takamata A, Ito T, Sessler DI, Kitamura Y, Shimosato G, Taniguchi S, Matsuyama H, Tanaka Y, Mizobe T. Upright posture reduces thermogenesis and augments core hypothermia. Anesth Analg. 2002;94(6):1646–51.PubMed

118.

Taniguchi Y, Lenhardt R, Sessler DI, Kurz A. The effect of altering skin-surface cooling speeds on vasoconstriction and shivering thresholds. Anesth Analg. 2011;113(3):540–4.PubMed

119.

Sweney MT, Sigg DC, Tahvildari S, Iaizzo PA. Shiver suppression using focal hand warming in unanesthetized normal subjects. Anesthesiology. 2001;95(5):1089–95.PubMedCrossRef

120.

Iaizzo PA, Jeon YM, Sigg DC. Facial warming increases the threshold for shivering. J Neurosurg Anesthesiol. 1999;11(4):231–9.PubMedCrossRef

121.

Mort TC, Rintel TD, Altman F. The effects of forced-air warming on postbypass central and skin temperatures and shivering activity. J Clin Anesth. 1996;8(5):361–70.PubMedCrossRef

122.

Badjatia N, Strongilis E, Prescutti M, Fernandez L, Fernandez A, Buitrago M, Schmidt JM, Mayer SA. Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med. 2009;37(6):1893–7.PubMedCrossRef

123.

Nakamura T, Nagao S, Kawai N, Honma Y, Kuyama H. Significance of multimodal cerebral monitoring under moderate therapeutic hypothermia for severe head injury. Acta neurochir Suppl. 1998;71:85–7.PubMed

124.

Nakamura T, Kuroda Y, Torigoe N, Abe Y, Yamashita S, Kawakita K, Kawai N, Tamiya T, Itano T, Nagao S. Cerebral metabolism monitoring during hypothermia following resuscitation from cardiopulmonary arrest. Acta Neurochir Suppl. 2008;102:203–6.PubMedCrossRef

125.

Le Roux P, Menon DK, Citerio G, Vespa P, Bader MK, Brophy GM, Diringer MN, Stocchetti N, Videtta W, Armonda R et al: Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Neurocritical care 2014, 21 Suppl 2:S1–26.

126.

Bardutzky J, Georgiadis D, Kollmar R, Schwab S. Energy expenditure in ischemic stroke patients treated with moderate hypothermia. Intensive Care Med. 2004;30(1):151–4.PubMedCrossRef

127.

Holzinger U, Brunner R, Losert H, Fuhrmann V, Herkner H, Madl C, Sterz F, Schneeweiss B: Resting energy expenditure and substrate oxidation rates correlate to temperature and outcome after cardiac arrest - a prospective observational cohort study. Critical care (London, England) 2015, 19:128.

128.

Oshima T, Furukawa Y, Kobayashi M, Sato Y, Nihei A, Oda S. Fulfilling caloric demands according to indirect calorimetry may be beneficial for post cardiac arrest patients under therapeutic hypothermia. Resuscitation. 2015;88:81–5.PubMedCrossRef

129.

Jalan R, SW OD, Deutz NE, Lee A, Hayes PC: Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999, 354(9185):1164–1168.

130.

Dobak S, Rincon F: Enteral feeding during induced hypothermia after intracerebral hemorrhage. Neurology 2016, 86(16).

131.

Hata JS, Shelsky CR, Hindman BJ, Smith TC, Simmons JS, Todd MM. A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury. Neurocrit Care. 2008;9(1):37–44.PubMedCrossRef

132.

Osuka A, Uno T, Nakanishi J, Hinokiyama H, Takahashi Y, Matsuoka T: Energy expenditure in patients with severe head injury: controlled normothermia with sedation and neuromuscular blockade. J Crit Care 2013, 28(2):218 e219-213.

133.

Chmayssani M, Stein NR, McArthur DL, Vespa PM. Therapeutic intravascular normothermia reduces the burden of metabolic crisis. Neurocrit Care. 2015;22(2):265–72.PubMedCrossRef

134.

Mtaweh H, Smith R, Kochanek PM, Wisniewski SR, Fabio A, Vavilala MS, Adelson PD, Toney NA, Bell MJ. Energy expenditure in children after severe traumatic brain injury. Pediatr Crit Care Med. 2014;15(3):242–9.PubMedPubMedCentralCrossRef

135.

Williams ML, Nolan JP. Is enteral feeding tolerated during therapeutic hypothermia? Resuscitation. 2014;85(11):1469–72.PubMedCrossRef

136.

Taylor BE, McClave SA, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.). Crit Care Med. 2016;44(2):390–438.PubMedCrossRef

137.

Nielsen N: Target temperature management after out-of-hospital cardiac arrest. Circulation 2011, 124(21 suppl. 1).

138.

Perbet S, Mongardon N, Dumas F, Bruel C, Lemiale V, Mourvillier B, Carli P, Varenne O, Mira JP, Wolff M, et al. Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Resp Crit Care. 2011;184(9):1048–54.CrossRef

139.

Hashiguchi N, Shiozaki T, Ogura H, Tanaka H, Koh T, Noborio M, Fugita K, Akimau P, Kuwagata Y, Shimazu T, et al. Mild hypothermia reduces expression of heat shock protein 60 in leukocytes from severely head-injured patients. J Trauma. 2003;55(6):1054–60.PubMedCrossRef

140.

Fries MS, C.;Brucken, D.;Rossaint, R.;Kuhlen, R.: Influence of mild therapeutic hypothermia on the inflammatory response after successful resuscitation from cardiac arrest. J Crit Care 2009, 24(3):453–457.

141.

Jacob M, Hassager C, Bro-Jeppesen J, Ostrowski SR, Thomsen JH, Wanscher M, Johansson PI, Winther-Jensen M, Kjærgaard J. The effect of targeted temperature management on coagulation parameters and bleeding events after out-of-hospital cardiac arrest of presumed cardiac cause. Resuscitation. 2015;96:260–7.PubMedCrossRef

142.

Maekawa T, Yamashita S, Nagao S, Hayashi N, Ohashi Y. Prolonged mild therapeutic hypothermia versus fever control with tight hemodynamic monitoring and slow rewarming in patients with severe traumatic brain injury: a randomized controlled trial. J Neurotrauma. 2015;32(7):422–9.PubMedPubMedCentralCrossRef

143.

Perrone S, Szabo M, Bellieni CV, Longini M, Bango M, Kelen D, Treszl A, Negro S, Tataranno ML, Buonocore G. Whole body hypothermia and oxidative stress in babies with hypoxic-ischemic brain injury. Pediatr Neurol. 2010;43(4):236–40.PubMedCrossRef

144.

Staykov D, Wagner I, Volbers B, Doerfler A, Schwab S, Kollmar R. Mild prolonged hypothermia for large intracerebral hemorrhage. Neurocrit Care. 2013;18(2):178–83.PubMedCrossRef

145.

Tokutomi T, Miyagi T, Morimoto K, Karukaya T, Shigemori M. Effect of hypothermia on serum electrolyte, inflammation, coagulation, and nutritional parameters in patients with severe traumatic brain injury. Neurocrit Care. 2004;1(2):171–82.PubMedCrossRef

146.

Ishikawa K, Tanaka H, Shiozaki T, Takaoka M, Ogura H, Kishi M, Shimazu T, Sugimoto H. Characteristics of infection and leukocyte count in severely head-injured patients treated with mild hypothermia. J Trauma. 2000;49(5):912–22.PubMedCrossRef

147.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.PubMedCrossRef

148.

O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American college of critical care medicine and the infectious diseases society of America. Crit Care Med. 2008;36(4):1330–49.PubMedCrossRef

149.

Mirzoyev SA, McLeod CJ, Bunch TJ, Bell MR, White RD. Hypokalemia during the cooling phase of therapeutic hypothermia and its impact on arrhythmogenesis. Resuscitation. 2010;81(12):1632–6.PubMedCrossRef

150.

Koht A, Cane R, Cerullo LJ. Serum potassium levels during prolonged hypothermia. Intensive Care Med. 1983;9(5):275–7.PubMedCrossRef

151.

Eastwood GM, Suzuki S, Lluch C, Schneider AG, Bellomo R. A pilot assessment of alpha-stat vs pH-stat arterial blood gas analysis after cardiac arrest. J Crit Care. 2015;30(1):138–44.PubMedCrossRef

152.

Zeiner A, Sunder-Plassmann G, Sterz F, Holzer M, Losert H, Laggner AN, Mullner M. The effect of mild therapeutic hypothermia on renal function after cardiopulmonary resuscitation in men. Resuscitation. 2004;60(3):253–61.PubMedCrossRef

153.

Zhao QJ, Zhang XG, Wang LX. Mild hypothermia therapy reduces blood glucose and lactate and improves neurologic outcomes in patients with severe traumatic brain injury. J Crit Care. 2011;26(3):311–5.PubMedCrossRef

154.

Cueni-Villoz N, Devigili A, Delodder F, Cianferoni S, Feihl F, Rossetti AO, Eggimann P, Vincent JL, Taccone FS, Oddo M. Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med. 2011;39(10):2225–31.PubMedCrossRef

155.

Ettleson MD, Arguello V, Wallia A, Arguelles L, Bernstein RA, Molitch ME. Hyperglycemia and insulin resistance in cardiac arrest patients treated with moderate hypothermia. J Clin Endocrinol Metab. 2014;99(10):E2010–4.PubMedCrossRef

156.

Sunjic KM, Webb AC, Sunjic I, Pala Creus M, Folse SL. Pharmacokinetic and other considerations for drug therapy during targeted temperature management. Crit Care Med. 2015;43(10):2228–38.PubMedCrossRef

157.

Heier T, Clough D, Wright PM, Sharma ML, Sessler DI, Caldwell JE. The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers. Anesthesiology. 2002;97(1):90–5.PubMedCrossRef

158.

Souckova L, Opatrilova R, Suk P, Cundrle I Jr, Pavlik M, Zvonicek V, Hlinomaz O, Sramek V. Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR). Eur J Clin Pharmacol. 2013;69(3):309–17.PubMedCrossRef

159.

Kaufmann J, Wellnhofer E, Stockmann H, Graf K, Fleck E, Schroeder T, Stawowy P, Storm C. Clopidogrel pharmacokinetics and pharmacodynamics in out-of-hospital cardiac arrest patients with acute coronary syndrome undergoing target temperature management. Resuscitation. 2016;102:63–9.PubMedCrossRef

160.

Bednar F, Kroupa J, Ondrakova M, Osmancik P, Kopa M, Motovska Z. Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction. J Thromb Thrombolysis. 2016;41(4):549–55.PubMedCrossRef

161.

Joffre JV, O.; Bougouin, W.; Rosencher, J.; Mira, J.P.: Stent thrombosis: an increased adverse sevent after angioplasty following resuscitated cardiac arrest. Resuscitation 2014, 85:769–773.

162.

Tilemann LMS, J.;Zelniker, T.;Chorianopoulos, E.;Giannitsis, E.;Katus, H. A.;Muller, O. J.;Preusch, M.: Efficacy of enteral ticagrelor in hypothermic patients after out-of-hospital cardiac arrest. Clin Res Cardiol 2016, 105(4):332–340.

163.

Steblovnik K, Blinc A, Mijovski MB, Fister M, Mikuz U, Noc M. Ticagrelor versus clopidogrel in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and hypothermia: a randomized study. Circulation. 2016;134(25):2128–30.PubMedCrossRef

164.

Fukuoka N, Aibiki M, Tsukamoto T, Seki K, Morita S. Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia. Resuscitation. 2004;60(2):225–30.PubMedCrossRef

165.

Bjelland TW, Klepstad P, Haugen BO, Nilsen T, Salvesen O, Dale O. Concentrations of remifentanil, propofol, fentanyl, and midazolam during rewarming from therapeutic hypothermia. Acta Anaesthesiol Scand. 2014;58(6):709–15.PubMedCrossRef

166.

Bjelland TW, Klepstad P, Haugen BO, Nilsen T, Dale O. Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients. Drug Metab Dispos. 2013;41(1):214–23.PubMedCrossRef

167.

Leslie K, Sessler DI, Bjorksten AR, Moayeri A. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg. 1995;80(5):1007–14.PubMed

168.

Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007;35(9):2196–204.PubMedCrossRef

169.

Caldwell JE, Heier T, Wright PM, Lin S, McCarthy G, Szenohradszky J, Sharma ML, Hing JP, Schroeder M, Sessler DI. Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2000;92(1):84–93.PubMedCrossRef

170.

Beaufort AM, Wierda JM, Belopavlovic M, Nederveen PJ, Kleef UW, Agoston S. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anesth Suppl. 1995;11(Suppl):95–106.

171.

Iida Y, Nishi S, Asada A. Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics. Ther Drug Monit. 2001;23(3):192–7.PubMedCrossRef

172.

Bagna FC, Pitoni S, Andrews PJD. Therapeutic mild hypothermia and the pharmacokinetics of drugs in Trauma Brain Injury (TBI) patients with a focus on sedation, anticonvulsant and antibiotic therapy. Open Crit Care Med J. 2013;6(1):31–8.CrossRef

173.

Empey PE, Velez de Mendizabal N, Bell MJ, Bies RR, Anderson KB, Kochanek PM, Adelson PD, Poloyac SM, Pediatric TBICHI: Therapeutic hypothermia decreases phenytoin elimination in children with traumatic brain injury. Crit Care Med 2013, 41(10):2379–2387.

174.

Wahby KA, Jhajhria S, Dalal BD, Soubani AO. Heparin dosing in critically ill patients undergoing therapeutic hypothermia following cardiac arrest. Resuscitation. 2014;85(4):533–7.PubMedCrossRef

175.

Fevold RT, Leung YT, Garofoli AC, White RD, Barsness GW, Dierkhising RA, Ou NN. Heparin dose adjustment required to maintain goal-activated partial thromboplastin time during therapeutic hypothermia. J Crit Care. 2015;30(3):574–8.PubMedCrossRef

176.

Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37(3):1101–20.PubMedCrossRef

177.

Jeppesen AN, Kirkegaard H, Ilkjær S, Hvas AM. Influence of temperature on thromboelastometry and platelet aggregation in cardiac arrest patients undergoing targeted temperature management. Crit Care. 2016;20(1):118.PubMedPubMedCentralCrossRef

178.

Chih-Hung W, Nai-Chuan C, Min-Shan T, Ping-Hsun Y, An-Yi W, Wei-Tien C, Chien-Hua H, Wen-Jone C, Wang C-H, Chen N-C, et al. Therapeutic hypothermia and the risk of hemorrhage: a systematic review and meta-analysis of randomized controlled trials. Medicine. 2015;94(47):1–8.

179.

Stockmann H, Krannich A, Schroeder T, Storm C. Therapeutic temperature management after cardiac arrest and the risk of bleeding: systematic review and meta-analysis. Resuscitation. 2014;85(11):1494–503.PubMedCrossRef

180.

Wu TC, Grotta JC. Hypothermia for acute ischaemic stroke. Lancet Neurol. 2013;12(3):275–84.PubMedCrossRef

181.

Todd MM, Hindman BJ, Clarke WR, Torner JC. Intraoperative hypothermia for aneurysm surgery trial I: mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352(2):135–45.PubMedCrossRef

182.

Seule M, Keller E. Hypothermia after aneurysmal subarachnoid hemorrhage. Crit Care. 2012;16(Suppl 2):A16.PubMedCentralCrossRef

183.

Stiller K. Physiotherapy in intensive care: an updated systematic review. Chest. 2013;144(3):825–47.PubMedCrossRef

184.

Hodgson CL, Berney S, Harrold M, Saxena M, Bellomo R. Clinical review: early patient mobilization in the ICU. Crit Care. 2013;17(1):207.PubMedPubMedCentralCrossRef

185.

Cumming TB, Thrift AG, Collier JM, Churilov L, Dewey HM, Donnan GA, Bernhardt J. Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke. 2011;42(1):153–8.PubMedCrossRef

186.

Jarrah S, Dziodzio J, Lord C, Fraser GL, Lucas L, Riker RR, Seder DB. Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice. Neurocrit Care. 2011;14(3):382–8.PubMedCrossRef

187.

Mayer SA, Kowalski RG, Presciutti M, Ostapkovich ND, McGann E, Fitzsimmons BF, Yavagal DR, Du YE, Naidech AM, Janjua NA, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004;32(12):2508–15.PubMedCrossRef

188.

Varon J, Acosta P, Wintz R, Mendoza N. Unusual side effect from hydrogel pads during therapeutic hypothermia. Resuscitation. 2008;78(3):248–9.PubMedCrossRef

189.

Leary M, Cinousis MJ, Mikkelsen ME, Gaieski DF, Abella BS, Fuchs BD. The association of body mass index with time to target temperature and outcomes following post-arrest targeted temperature management. Resuscitation. 2014;85(2):244–7.PubMedCrossRef

190.

De Georgia MA, Krieger DW, Abou-Chebl A, Devlin TG, Jauss M, Davis SM, Koroshetz WJ, Rordorf G, Warach S. Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology. 2004;63(2):312–7.PubMedCrossRef

191.

Piironen K, Tiainen M, Mustanoja S, Kaukonen KM, Meretoja A, Tatlisumak T, Kaste M. Mild hypothermia after intravenous thrombolysis in patients with acute stroke: a randomized controlled trial. Stroke. 2014;45(2):486–91.PubMedCrossRef

192.

Tiainen M, Parikka HJ, Makijarvi MA, Takkunen OS, Sarna SJ, Roine RO. Arrhythmias and heart rate variability during and after therapeutic hypothermia for cardiac arrest. Crit Care Med. 2009;37(2):403–9.PubMedCrossRef

193.

Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365(9460):663–70.PubMedCrossRef

194.

Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K, et al. Therapeutic hypothermia after in-hospital cardiac arrest in children. N Engl J Med. 2017;376(4):318–29.PubMedPubMedCentralCrossRef

195.

Bourdages M, Bigras JL, Farrell CA, Hutchison JS, Lacroix J. Canadian critical care trials G: cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy. Pediatr Crit Care Med. 2010;11(3):408–14.PubMed

196.

Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, et al. Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol. 2005;32(1):18–24.PubMedCrossRef

197.

Beca J, McSharry B, Erickson S, Yung M, Schibler A, Slater A, Wilkins B, Singhal A, Williams G, Sherring C, et al. Hypothermia for traumatic brain injury in children-A phase II randomized controlled trial. Crit Care Med. 2015;43(7):1458–66.PubMedCrossRef

198.

Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, Wright IM, Kirpalani HM, Darlow BA, Doyle LW, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165(8):692–700.PubMedCrossRef

199.

Merchant RM, Becker LB, Abella BS, Asch DA, Groeneveld PW. Cost-effectiveness of therapeutic hypothermia after cardiac arrest. Circ Cardiovasc Qual Outcomes. 2009;2(5):421–8.PubMedCrossRef

200.

Gajarski RJ, Smitko K, Despres R, Meden J, Hutton DW. Cost-effectiveness analysis of alternative cooling strategies following cardiac arrest. SpringerPlus. 2015;4:427.PubMedPubMedCentralCrossRef

201.

Argibay-Lago A, Fernandez-Rodriguez D, Ferrer-Sala N, Prieto-Robles C, Hernanz-del Rio A, Castro-Rebollo P. Evaluation of nurse workload in patients undergoing therapeutic hypothermia. Enferm Clin. 2014;24(6):323–9.PubMedCrossRef

202.

Krawczyk P, Kolodziej G, Szpyra B, Andres J. Implementation of therapeutic hypothermia after cardiac arrest in intensive care units in Poland. Kardiol Pol. 2013;71(3):270–4.PubMedCrossRef

203.

Olson DM, Kelly AP, Washam NC, Thoyre SM. Critical care nurses’ workload estimates for managing patients during induced hypothermia. Nurs Crit Care. 2008;13(6):305–9.PubMedCrossRef

204.

Toma A, Bensimon CM, Dainty KN, Rubenfeld GD, Morrison LJ, Brooks SC. Perceived barriers to therapeutic hypothermia for patients resuscitated from cardiac arrest: a qualitative study of emergency department and critical care workers. Crit Care Med. 2010;38(2):504–9.PubMedCrossRef

205.

Vaga A, Busch M, Karlsen TE, Nilsen OB, Soreide E. A pilot study of key nursing aspects with different cooling methods and devices in the ICU. Resuscitation. 2008;76(1):25–30.PubMedCrossRef

Titel: The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society
verfasst von: Lori Kennedy Madden
Michelle Hill
Teresa L. May
Theresa Human
Mary McKenna Guanci
Judith Jacobi
Melissa V. Moreda
Neeraj Badjatia
Publikationsdatum: 16.10.2017
Verlag: Springer US
Erschienen in: Neurocritical Care / Ausgabe 3/2017
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-017-0469-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Factors Considered by Clinicians when Prognosticating Intracerebral Hemorrhage Outcomes

Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0

Infections in Neurocritical Care

Medical Management of the Severe Traumatic Brain Injury Patient

Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia